News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
882,528 Results
Type
Article (88701)
Company Profile (816)
Press Release (792988)
Multimedia
Podcasts (234)
Webinars (35)
Section
Business (233554)
Career Advice (4161)
Deals (39967)
Drug Delivery (176)
Drug Development (91667)
Employer Resources (207)
FDA (18546)
Job Trends (17480)
News (398650)
Policy (40012)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3049)
Academic (2)
Accelerated approval (54)
Adcomms (40)
Allergies (189)
Alliances (56988)
ALS (228)
Alzheimer's disease (1956)
Antibody-drug conjugate (ADC) (533)
Approvals (18862)
Artificial intelligence (842)
Autoimmune disease (342)
Automation (62)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (242)
Biotechnology (480)
Bladder cancer (210)
Brain cancer (84)
Breast cancer (822)
Cancer (6401)
Cardiovascular disease (546)
Career advice (3595)
Career pathing (51)
CAR-T (370)
CDC (76)
Celiac Disease (3)
Cell therapy (1044)
Cervical cancer (51)
Clinical research (78734)
Collaboration (2312)
Company closure (8)
Compensation (1466)
Complete response letters (103)
COVID-19 (3037)
CRISPR (121)
C-suite (1248)
Cystic fibrosis (166)
Data (8412)
Decentralized trials (3)
Denatured (89)
Depression (190)
Dermatology (94)
Diabetes (651)
Diagnostics (7556)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (414)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (311)
Earnings (102461)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138224)
Executive appointments (1178)
FDA (22524)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1891)
Gene editing (267)
Generative AI (87)
Gene therapy (841)
GLP-1 (1260)
Government (5553)
Grass and pollen (8)
Guidances (417)
Healthcare (21207)
HIV (91)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (107)
Immunology and inflammation (351)
Immuno-oncology (111)
Indications (198)
Infectious disease (3427)
Inflammatory bowel disease (240)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (309)
Interviews (820)
IPO (17996)
IRA (61)
Job creations (5206)
Job search strategy (2871)
JPM (73)
Kidney cancer (22)
Labor market (117)
Layoffs (683)
Leadership (52)
Legal (10171)
Liver cancer (110)
Longevity (36)
Lung cancer (846)
Lymphoma (451)
Machine learning (65)
Management (66)
Manufacturing (1186)
MASH (220)
Medical device (15255)
Medtech (15394)
Mergers & acquisitions (23251)
Metabolic disorders (1744)
mRNA (258)
Multiple sclerosis (202)
NASH (24)
Neurodegenerative disease (490)
Neuropsychiatric disorders (126)
Neuroscience (3654)
Neurotech (2)
NextGen: Class of 2026 (7714)
Non-profit (5140)
Now hiring (80)
Obesity (838)
Opinion (371)
Ovarian cancer (239)
Pain (281)
Pancreatic cancer (329)
Parkinson's disease (405)
Partnered (39)
Patents (640)
Patient recruitment (727)
Peanut (67)
People (67877)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24333)
Phase 2 (34199)
Phase 3 (25716)
Pipeline (9368)
Policy (394)
Postmarket research (3559)
Preclinical (10949)
Press Release (72)
Prostate cancer (335)
Psychedelics (68)
Radiopharmaceuticals (366)
Rare diseases (1227)
Real estate (7461)
Recruiting (81)
Regulatory (30250)
Reports (77)
Research institute (2767)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (28)
RSV (98)
Schizophrenia (194)
Series A (318)
Series B (229)
Service/supplier (28)
Sickle cell disease (122)
Special edition (32)
Spinal muscular atrophy (189)
Sponsored (55)
Startups (4368)
State (2)
Stomach cancer (21)
Supply chain (143)
Tariffs (104)
The Weekly (142)
Vaccines (1290)
Venture capital (128)
Weight loss (577)
Women's health (136)
Worklife (24)
Date
Today (58)
Last 7 days (668)
Last 30 days (3357)
Last 365 days (32957)
2026 (14887)
2025 (33222)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (395)
Arkansas (16)
Asia (52197)
Australia (9179)
California (14124)
Canada (3959)
China (1511)
Colorado (605)
Connecticut (627)
Delaware (434)
Europe (120359)
Florida (2093)
Georgia (461)
Hawaii (4)
Idaho (70)
Illinois (1213)
India (101)
Indiana (653)
Iowa (25)
Japan (575)
Kansas (142)
Kentucky (56)
Louisiana (50)
Maine (89)
Maryland (1716)
Massachusetts (10304)
Michigan (421)
Minnesota (786)
Mississippi (7)
Missouri (162)
Montana (37)
Nebraska (30)
Nevada (152)
New Hampshire (92)
New Jersey (3744)
New Mexico (34)
New York (3706)
North Carolina (1910)
North Dakota (11)
Northern California (7010)
Ohio (438)
Oklahoma (26)
Oregon (55)
Pennsylvania (2796)
Puerto Rico (30)
Rhode Island (53)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5526)
Tennessee (223)
Texas (2292)
United States (50515)
Utah (422)
Vermont (1)
Virginia (357)
Washington D.C. (89)
Washington State (1163)
West Virginia (4)
Wisconsin (157)
Wyoming (2)
There are 882,528 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
June 1, 2026
·
7 min read
Press Releases
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
June 1, 2026
·
7 min read
Press Releases
ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
June 1, 2026
·
14 min read
Press Releases
Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting
June 1, 2026
·
5 min read
Press Releases
Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026
June 1, 2026
·
6 min read
Press Releases
Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
June 1, 2026
·
11 min read
Press Releases
Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
June 1, 2026
·
4 min read
Press Releases
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
June 1, 2026
·
12 min read
Press Releases
Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
June 1, 2026
·
15 min read
Press Releases
ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026
June 1, 2026
·
4 min read
1 of 88,253
Next
